These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2650161)

  • 1. Vanishing bile duct syndrome in canine liver allotransplants.
    Uchida H; Tomikawa S; Nishimura Y; Yokota K; Sato K; Osakabe T; Nakayama Y; Takishima T; Yamagishi K; Masaki Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):404-6. PubMed ID: 2650161
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary sclerosing cholangitis, a vanishing bile duct disease.
    van Berge Henegouwen GP
    Neth J Med; 1987 Aug; 31(1-2):27-35. PubMed ID: 3658059
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine.
    Sato K; Yokota K; Matsui T; Imai K; Takishima T; Nakayama Y; Osakabe T; Yoshida M; Mieno H; Omiya H
    Transplant Proc; 1991 Dec; 23(6):3296-9. PubMed ID: 1721440
    [No Abstract]   [Full Text] [Related]  

  • 4. [Canine orthotopic liver transplantation].
    Uchida H; Yokota K; Sato K; Osakabe T; Nakayama Y; Takishima T; Aso K
    Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1718-30. PubMed ID: 3328820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts.
    Martelius T; Krogerus L; Höckerstedt K; Bruggeman C; Lautenschlager I
    Hepatology; 1998 Apr; 27(4):996-1002. PubMed ID: 9537439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome.
    van Hoek B; Wiesner RH; Ludwig J; Paya C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1442-3. PubMed ID: 1703343
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible vanishing bile duct syndrome after liver transplantation: report of 6 cases.
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger JM
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1415-6. PubMed ID: 1989250
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion from cyclosporine to bredinin in canine orthotopic liver transplantation.
    Uchida H; Yokota K; Sato K; Masaki Y; Osakabe T; Nakayama Y; Takishima T; Aso K
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1290-4. PubMed ID: 3547860
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation.
    van Hoek B; Wiesner RH; Ludwig J; Gores GJ; Moore B; Krom RA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1403-5. PubMed ID: 1989248
    [No Abstract]   [Full Text] [Related]  

  • 11. Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression.
    Imai K; Sato K; Takishima T; Nakayama Y; Osakabe T; Yokota K; Yamagishi K; Uchida H; Hiki Y
    Transplant Proc; 1990 Aug; 22(4):1655-7. PubMed ID: 1697117
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution.
    Noack KB; Wiesner RH; Batts K; van Hoek B; Ludwig J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1448-51. PubMed ID: 1989260
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of host liver damage, portacaval shunt, and various immunosuppressive regimes on canine auxiliary liver transplantation.
    Macpherson SG; Miller SE; Calman KC; McSween RN; Buxton BF; Bell PR
    Transplantation; 1972 Aug; 14(2):175-82. PubMed ID: 4558905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reconstruction of the bile duct - a still unsolved problem of liver transplantation].
    Strebel HM; Weber M; Scholl E
    Helv Chir Acta; 1974 Mar; 41(1-2):25-7. PubMed ID: 4611978
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
    Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vanishing bile duct syndrome].
    Hashimoto E; Hayashi N
    Ryoikibetsu Shokogun Shirizu; 1995; (7):574-6. PubMed ID: 8749558
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholestasis in ulcerative colitis. Pathology.
    Smuckler EA
    Gastroenterology; 1977 Aug; 73(2):368-71. PubMed ID: 873145
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations on experimental and clinical liver transplantation.
    Caine RY
    Transplant Proc; 1972 Dec; 4(4):773-9. PubMed ID: 4630300
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.
    Amemiya H; Suzuki S; Watanabe H; Hayashi R; Niiya S
    Transplant Proc; 1989 Feb; 21(1 Pt 1):956-8. PubMed ID: 2650298
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative studies of FK506 and cyclosporine in canine orthotopic hepatic allograft survival.
    Yokota K; Takishima T; Sato K; Osakabe T; Nakayama Y; Uchida H; Aso K; Masaki Y; Ohbu M; Okudaira M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1066-8. PubMed ID: 2468209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.